首页> 外文学位 >Development of peptide inhibitors targeting Clostridium difficile toxins A/B and characterizing the regulatory role of a putative negative regulator TcdC in Clostridium difficile toxin gene expression.
【24h】

Development of peptide inhibitors targeting Clostridium difficile toxins A/B and characterizing the regulatory role of a putative negative regulator TcdC in Clostridium difficile toxin gene expression.

机译:靶向艰难梭菌毒素A / B的肽抑制剂的开发以及表征推定的负调节剂TcdC在艰难梭菌毒素基因表达中的调节作用。

获取原文
获取原文并翻译 | 示例

摘要

Clostridium difficile infections cause one of the most common and vital hospitalacquired diseases often associated with broad-spectrum antibiotic usage. TcdA and TcdB are the key virulence factors involved in major patho-physiology. While standard antibiotics provide some respite, due to the high relapse rates and the emergence of more severe disease presentations, antibiotics alone have often proven to be suboptimal. Therefore there is a desperate need to develop an effective non-antimicrobial therapeutics. Part of this work focuses on identification and further characterization of peptide therapeutic that target the major virulence factor TcdA/TcdB. Towards development of mechanistic-based anti-toxin agent, phage display was used to identify peptides that bind to the catalytic domain of C. difficile Toxin A. Characterization of the binding and inhibitory activity revealed that the lack of parent peptide ability to inhibit the cells in vivo. Further derivatization of above parent peptides in to irreversible binders lead to protects cells in vivo. Mass spectroscopy approaches revealed the peptide inhibition was mainly due to cross-linking of modified peptide in to key catalytic residues in active site. While there are still several steps required to further explore in terms of the stability of these compounds, agents like these could be potentially used prophylactically 163 to avoid extensive cellular damage during treatment with broad spectrum antibiotics or in populations prone to CDI.;The other area, focused on this thesis, is identification of the functional role of a negative regulator (TcdC) involved in toxin gene expression. In this work, we used a variety of biochemical and genetic approaches and characterized TcdC is not repressor instead acts as an Extra Cytoplasmic Class (ECF) anti-sigma factor and was able to propose a new mechanistic model regarding the regulatory role of TcdC. As well as here we have successfully developed GFP-based reporter system which has a potential to be an adaptable tool for investigating fine details on toxin genes tuning. Being able to adopt in host environment is vital for survival and propagation of a pathogenic bacteria. Thus, exploring the regulatory nodes on PaLoc gene expression can be lead to exploit potential therapeutic opportunities hidden within such systems.
机译:艰难梭菌感染是最常见和最重要的医院获得性疾病之一,通常与广谱抗生素的使用有关。 TcdA和TcdB是参与主要病理生理的关键毒力因子。尽管标准抗生素提供了一定的喘息机会,但由于复发率高和出现更严重的疾病表现,单单抗生素常常被证明是次优的。因此,迫切需要开发有效的非抗菌疗法。这项工作的一部分重点在于针对主要毒力因子TcdA / TcdB的肽治疗剂的鉴定和进一步表征。为了发展基于机理的抗毒素剂,噬菌体展示被用于鉴定与艰难梭菌毒素A催化域结合的肽。结合和抑制活性的表征表明,缺乏亲本肽抑制细胞的能力体内。将上述亲本肽进一步衍生为不可逆的结合物可在体内保护细胞。质谱方法揭示了肽的抑制主要是由于修饰的肽与活性位点的关键催化残基的交联。尽管就这些化合物的稳定性而言仍需要进一步探索几个步骤,但类似的药物可能会被预防性地使用163,以避免在广谱抗生素治疗期间或易发生CDI的人群中发生广泛的细胞损伤。本论文的重点是鉴定与毒素基因表达有关的负调节剂(TcdC)的功能。在这项工作中,我们使用了多种生化和遗传方法,并表征了TcdC并非阻遏物,而是充当细胞外质类(ECF)抗-sigma因子,并能够提出有关TcdC调控作用的新机制模型。除此之外,我们还成功开发了基于GFP的报告系统,该系统有可能成为研究毒素基因微调细节的适应性工具。能够在宿主环境中采用对于病原菌的生存和繁殖至关重要。因此,探索PaLoc基因表达的调控节点可导致利用隐藏在此类系统中的潜在治疗机会。

著录项

  • 作者

    Abdeen, Sanofar J.;

  • 作者单位

    Wayne State University.;

  • 授予单位 Wayne State University.;
  • 学科 Chemistry Biochemistry.
  • 学位 Ph.D.
  • 年度 2013
  • 页码 179 p.
  • 总页数 179
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 11:41:32

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号